Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
About Tender
🚂 Procurement Opportunity: Mft Ear Drops 💊 The Ministry Of Railways, Under The Central Government, Invites Tenders For The Supply Of Mft Ear Drops Containing Lidocaine/Lignocaine 1.73%, W/V, Clotrimazole 1.0%, W/V, Ofloxacin 0.30%, W/V, And Beclomethasone Dipropionate 0.25%, W/V. 📅 Bid Submission Deadline: April 4, 2024, 10:30 Am Tender Fees: Inr 0 Emd: Inr 0 Interested Pharmaceutical Suppliers Must Submit Detailed Bids, Including Product Specifications, Manufacturing Processes, Quality Control Measures, And Pricing, In Accordance With The Tender Document For Complete Details. Keywords: Mft Ear Drops, Lidocaine/Lignocaine, Clotrimazole, Ofloxacin, Beclomethasone Dipropionate, Ministry Of Railways, Tender, Pharmaceutical Supplies, Government Procurement| Particulars | Details |
|---|---|
| Title |
Mft (Ph No.:35100) Lidocaine/ Lignocaine 1.73 2 Percent W/V Clotrimazole 1.0 Percent Ofloxacin 0.30 Percent W/V Beclomethasone Dipropionate 0.25 Percent W/V Ear Drops
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106306422 |
|
Reference Number |
82240473A |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | |
| Place | Secunderabad |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/042024/106306422/viewNitPdf_4526773.pdf |
| Start Date | April 02, 2024 17:55 |
| End Date |
Expired
04/04/2024
Expired 812 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Mft (ph no.:35100) lidocaine/ lignocaine 1.73 -2 percent w/v clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear drops
For complete deion and other details, please refer to tender
Read moreMft (ph no.:35100) lidocaine/ lignocaine 1.73 -2 percent w/v clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear drops
For complete deion and other details, please refer to tender
Read more(ned-drugs) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read more(ned-drugs) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read more(ned-drugs) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read more(div/sc, drug) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read more(div/sc, drug) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read more(div/sc, drug) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read moreCrs/tpty drug (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read more(div/sc, drug) (ph no.:35100) lidocaine/lignocaine 1.73-2 percent w/v, clotrimazole 1.0 percent ofloxacin 0.30 percent w/v beclomethasone dipropionate 0.25 percent w/v ear s
For complete deion and other details, please refer to tender
Read moreof your Industry type